Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Bidding war: API (ASX: API) share price up on new Sigma (ASX:SIG) bid

Australian Pharmaceutical Industries (ASX:API) share price up on Sigma Healthcare Ltd (ASX:SIG) versus Wesfarmers Ltd (ASX:WES) takeover bid.

The Australian Pharmaceutical Industries (ASX: API) share price is rising after Sigma Healthcare Ltd (ASX: SIG) competes with Wesfarmers Ltd (ASX: WES) to take over API.

API is best known for being the parent company of Priceline Pharmacy and Soul Pattinson Chemist, ClearSkincare and others.  The company is more than 100 years old.

Battle to take over API

Wesfarmers has been making moves to try and take over API since July 2021 with an initial offer of $1.38 per share which was rejected.

On 16 September 2021 Wesfarmers took another swing with an offer of $1.55 per share. The API board said that they intended to unanimously recommend the revised offer to shareholders. As long as no better offer came along, of course.

Sigma makes an offer for API

API announced today that it has received a takeover offer from Sigma. The offer is a combination of $0.35 in cash and 2.05 Sigma shares for each API share. This is a value of $1.57 per API share, based on the closing Sigma share price of $0.595 yesterday.

There will also be a “mix and match” option, between maximum cash or maximum shares, if the deal goes ahead.

The offer is in the very early stages and is subject to a laundry list of conditions including due diligence and regulatory approval. Of course, it will also need to be recommended by the API board and accepted by API shareholders.

Sigma synergies

Under this proposed offer, API shareholders would own around 48.8% of the merged company. Sigma believes that merging API into Sigma has benefits to API shareholders, with synergies between the two companies.

Sigma said that it has identified at least $45 million per annum of potential cost synergies by combining the two companies.

What is API going to do?

The API board said that the Sigma offer could represent a more favourable offer to API shareholders.

The board decided to allow Sigma to go ahead with its due diligence. This is along side the offer to Wesfarmers to perform its due diligence.

API noted that there is no guarantee that this potential deal with Sigma will go ahead.

There is also no guarantee that Wesfarmers will up its offer after this, we will just have to wait and see.

Final thoughts on the API share price

The API share price is up by over 5% to $1.54 at the time of writing. This is 1.9% lower than the Sigma offer value of $1.57 per share.

However the Sigma share price has also risen and is up over 3%. This is noteworthy as the Sigma offer includes Sigma shares.

Of course, we still have to wait and see what Wesfarmers might come back to the table with.

I’m very interested to see how this plays out. However, I am not a buyer of API with these takeover offers being priced in. I’m looking for other ASX growth shares opportunities.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content